Qing Xu

Person

South San Francisco, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Cycloalkyl pyrimidines as ferroportin inhibitors
- Patent number 11,746,100
- Issue date Sep 5, 2023
- Global Blood Therapeutics, Inc.
- Qing Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic compounds as histone methyltransferase inhibitors
- Patent number 11,661,410
- Issue date May 30, 2023
- Global Blood Therapeutics, Inc.
- Zhe Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic compounds as histone methyltransferase inhibitors
- Patent number 11,584,734
- Issue date Feb 21, 2023
- Global Blood Therapeutics, Inc.
- Ming Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and uses thereof for the modulation of hemoglobin
- Patent number 11,530,191
- Issue date Dec 20, 2022
- Global Blood Therapeutics, Inc.
- Brian W. Metcalf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of protein kinases
- Patent number 11,414,410
- Issue date Aug 16, 2022
- Alexion Pharmaceuticals, Inc.
- Shawn M. Bauer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ferroportin inhibitors and methods of use
- Patent number 11,286,243
- Issue date Mar 29, 2022
- Global Blood Therapeutics, Inc.
- Zhe Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and uses thereof for the modulation of hemoglobin
- Patent number 11,236,109
- Issue date Feb 1, 2022
- Global Blood Therapeutics, Inc.
- Zhe Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and uses thereof for the modulation of hemoglobin
- Patent number 11,053,195
- Issue date Jul 6, 2021
- Global Blood Therapeutics, Inc.
- Qing Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of hemoglobin
- Patent number 11,014,884
- Issue date May 25, 2021
- Global Blood Therapeutics, Inc.
- Brian W. Metcalf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and uses thereof for the modulation of hemoglobin
- Patent number 10,858,317
- Issue date Dec 8, 2020
- Global Blood Therapeutics, Inc.
- Qing Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and uses thereof for the modulation of hemoglobin
- Patent number 10,829,470
- Issue date Nov 10, 2020
- Global Blood Therapeutics, Inc.
- Brian W. Metcalf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of protein kinases
- Patent number 10,533,001
- Issue date Jan 14, 2020
- Portola Pharmaceuticals, Inc.
- Shawn M. Bauer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and uses thereof for the modulation of hemoglobin
- Patent number 10,450,269
- Issue date Oct 22, 2019
- Global Blood Therapeutics, Inc.
- Qing Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and uses thereof for the modulation of hemoglobin
- Patent number 10,435,393
- Issue date Oct 8, 2019
- Global Blood Therapeutics, Inc.
- Qing Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and uses thereof for the modulation of hemoglobin
- Patent number 10,315,991
- Issue date Jun 11, 2019
- Global Blood Therapeutics, Inc.
- Qing Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and uses thereof for the modulation of hemoglobin
- Patent number 10,266,551
- Issue date Apr 23, 2019
- Global Blood Therapeutics, Inc.
- Zhe Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bridged bicyclic kallikrein inhibitors
- Patent number 10,144,746
- Issue date Dec 4, 2018
- Global Blood Therapeutics, Inc.
- Zhe Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and uses thereof for the modulation of hemoglobin
- Patent number 10,100,040
- Issue date Oct 16, 2018
- Global Blood Therapeutics, Inc.
- Zhe Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and uses thereof for the modulation of hemoglobin
- Patent number 9,981,939
- Issue date May 29, 2018
- Global Blood Therapeutics, Inc.
- Brian W. Metcalf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzamides and nicotinamides as Syk modulators
- Patent number 9,902,688
- Issue date Feb 27, 2018
- Portola Pharmaceuticals, Inc.
- Zhaozhong J. Jia
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyridazine compounds as JAK inhibitors
- Patent number 9,834,548
- Issue date Dec 5, 2017
- Portola Pharmaceuticals, Inc.
- Qing Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bridged bicyclic kallikrein inhibitors
- Patent number 9,815,853
- Issue date Nov 14, 2017
- Global Blood Therapeutics, Inc.
- Zhe Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and uses thereof for the modulation of hemoglobin
- Patent number 9,776,960
- Issue date Oct 3, 2017
- Global Blood Therapeutics, Inc.
- Qing Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolopyridine pyrazolopyrimidine and related compounds
- Patent number 9,695,166
- Issue date Jul 4, 2017
- Global Blood Therapeutics, Inc.
- Zhe Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and uses thereof for the modulation of hemoglobin
- Patent number 9,604,999
- Issue date Mar 28, 2017
- Global Blood Therapeutics, Inc.
- Jason R. Harris
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of syk and JAK protein kinases
- Patent number 9,579,320
- Issue date Feb 28, 2017
- Portola Pharmaceuticals, Inc.
- Zhaozhong J. Jia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic dihydropyridone kinase inhibitors
- Patent number 9,533,986
- Issue date Jan 3, 2017
- Portola Pharmaceuticals, Inc.
- Anjali Pandey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic oxa-lactam kinase inhibitors
- Patent number 9,469,654
- Issue date Oct 18, 2016
- Portola Pharmaceuticals, Inc.
- Anjali Pandey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and uses thereof for the modulation of hemoglobin
- Patent number 9,458,139
- Issue date Oct 4, 2016
- Global Blood Therapeutics, Inc.
- Qing Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazine kinase inhibitors
- Patent number 9,359,308
- Issue date Jun 7, 2016
- Portola Pharmaceuticals, Inc.
- Yonghong Song
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CYCLOALKYL PYRIMIDINES AS FERROPORTIN INHIBITORS
- Publication number 20240140932
- Publication date May 2, 2024
- Global Blood Therapeutics, Inc.
- Qing Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
- Publication number 20230322704
- Publication date Oct 12, 2023
- Global Blood Therapeutics, Inc.
- Brian W. Metcalf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS
- Publication number 20230226074
- Publication date Jul 20, 2023
- Global Blood Therapeutics, Inc.
- Qing Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THIENO PYRIMIDINES AS FERROPORTIN INHIBITORS
- Publication number 20230159553
- Publication date May 25, 2023
- Global Blood Therapeutics, Inc.
- Qing Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS
- Publication number 20230002351
- Publication date Jan 5, 2023
- Global Blood Therapeutics, Inc.
- ZHE LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
- Publication number 20220402940
- Publication date Dec 22, 2022
- Global Blood Therapeutics, Inc.
- Zhe Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYCLOALKYL PYRIMIDINES AS FERROPORTIN INHIBITORS
- Publication number 20220396562
- Publication date Dec 15, 2022
- Global Blood Therapeutics, Inc.
- Qing Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
- Publication number 20220119407
- Publication date Apr 21, 2022
- Global Blood Therapeutics, Inc.
- Zhe Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
- Publication number 20210261520
- Publication date Aug 26, 2021
- Global Blood Therapeutics, Inc.
- Brian W. Metcalf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS
- Publication number 20200361896
- Publication date Nov 19, 2020
- Global Blood Therapeutics, Inc.
- Ming YU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF PROTEIN KINASES
- Publication number 20200239458
- Publication date Jul 30, 2020
- Portola Pharmaceuticals, Inc.
- Shawn M. Bauer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FERROPORTIN INHIBITORS AND METHODS OF USE
- Publication number 20200190045
- Publication date Jun 18, 2020
- Global Blood Therapeutics, Inc.
- ZHE LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATORS OF HEMOGLOBIN
- Publication number 20200140384
- Publication date May 7, 2020
- Global Blood Therapeutics, Inc.
- Brian W. Metcalf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
- Publication number 20200079732
- Publication date Mar 12, 2020
- Global Blood Therapeutics, Inc.
- Qing Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
- Publication number 20200048280
- Publication date Feb 13, 2020
- Global Blood Therapeutics, Inc.
- Zhe Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
- Publication number 20190300477
- Publication date Oct 3, 2019
- Global Blood Therapeutics, Inc.
- Qing XU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
- Publication number 20190202782
- Publication date Jul 4, 2019
- Global Blood Therapeutics, Inc.
- Qing XU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
- Publication number 20190112287
- Publication date Apr 18, 2019
- Global Blood Therapeutics, Inc.
- Brian W. Metcalf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOBLOGIN
- Publication number 20190010121
- Publication date Jan 10, 2019
- Global Blood Therapeutics, Inc.
- Qing XU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
- Publication number 20180201577
- Publication date Jul 19, 2018
- Global Blood Therapeutics, Inc.
- Qing XU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BRIDGED BICYCLIC KALLIKREIN INHIBITORS
- Publication number 20180194780
- Publication date Jul 12, 2018
- Global Blood Therapeutics, Inc.
- Zhe Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF PROTEIN KINASES
- Publication number 20180186783
- Publication date Jul 5, 2018
- Portola Pharmaceuticals, Inc.
- Shawn M. Bauer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
- Publication number 20170355713
- Publication date Dec 14, 2017
- Global Blood Therapeutics, Inc.
- Jason R. HARRIS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDAZINE COMPOUNDS AS JAK INHIBITORS
- Publication number 20170174673
- Publication date Jun 22, 2017
- Portola Pharmaceuticals, Inc.
- Qing Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BRIDGED BICYCLIC KALLIKREIN INHIBITORS
- Publication number 20160362427
- Publication date Dec 15, 2016
- Global Blood Therapeutics, Inc.
- Zhe Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZAMIDES AND NICOTINAMIDES AS SYK MODULATORS
- Publication number 20160318852
- Publication date Nov 3, 2016
- Portola Pharmaceuticals, Inc.
- Zhaozhong J. Jia
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
- Publication number 20160152602
- Publication date Jun 2, 2016
- Global Blood Therapeutics, Inc.
- Qing Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
- Publication number 20160083343
- Publication date Mar 24, 2016
- Global Blood Therapeutics, Inc.
- Qing XU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
- Publication number 20160083348
- Publication date Mar 24, 2016
- Global Blood Therapeutics, Inc.
- Qing XU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
- Publication number 20160046613
- Publication date Feb 18, 2016
- Global Blood Therapeutics, Inc.
- Brian W. METCALF
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Cycloalkyl pyrimidines as ferroportin inhibitors

Tricyclic compounds as histone methyltransferase inhibitors

Tricyclic compounds as histone methyltransferase inhibitors

Compounds and uses thereof for the modulation of hemoglobin

Inhibitors of protein kinases

Ferroportin inhibitors and methods of use

Compounds and uses thereof for the modulation of hemoglobin

Compounds and uses thereof for the modulation of hemoglobin

Modulators of hemoglobin

Compounds and uses thereof for the modulation of hemoglobin

Compounds and uses thereof for the modulation of hemoglobin

Inhibitors of protein kinases

Compounds and uses thereof for the modulation of hemoglobin

Compounds and uses thereof for the modulation of hemoglobin

Compounds and uses thereof for the modulation of hemoglobin

Compounds and uses thereof for the modulation of hemoglobin

Bridged bicyclic kallikrein inhibitors

Compounds and uses thereof for the modulation of hemoglobin

Compounds and uses thereof for the modulation of hemoglobin

Benzamides and nicotinamides as Syk modulators

Pyridazine compounds as JAK inhibitors

Bridged bicyclic kallikrein inhibitors

Compounds and uses thereof for the modulation of hemoglobin

Pyrazolopyridine pyrazolopyrimidine and related compounds

Compounds and uses thereof for the modulation of hemoglobin

Inhibitors of syk and JAK protein kinases

Bicyclic dihydropyridone kinase inhibitors

Bicyclic oxa-lactam kinase inhibitors

Compounds and uses thereof for the modulation of hemoglobin

Pyrazine kinase inhibitors

Patents Applicationslast 30 patents

CYCLOALKYL PYRIMIDINES AS FERROPORTIN INHIBITORS

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS

THIENO PYRIMIDINES AS FERROPORTIN INHIBITORS

TRICYCLIC COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

CYCLOALKYL PYRIMIDINES AS FERROPORTIN INHIBITORS

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

TRICYCLIC COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS

INHIBITORS OF PROTEIN KINASES

FERROPORTIN INHIBITORS AND METHODS OF USE

MODULATORS OF HEMOGLOBIN

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOBLOGIN

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

BRIDGED BICYCLIC KALLIKREIN INHIBITORS

INHIBITORS OF PROTEIN KINASES

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

PYRIDAZINE COMPOUNDS AS JAK INHIBITORS

BRIDGED BICYCLIC KALLIKREIN INHIBITORS

BENZAMIDES AND NICOTINAMIDES AS SYK MODULATORS

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN

COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN